Investigative Site Number: 8400004
Atlanta, Georgia 30329-3102
1 studies enrolling now · 1 studies all time
What they study most
Type 1 Diabetes
Studies at this site
- Long-Term Outcomes of Teplizumab in Routine Clinical Care — Recruiting now
Atlanta, Georgia 30329-3102
1 studies enrolling now · 1 studies all time
Type 1 Diabetes